SARTORIUS STED BIO (EPA:DIM) | WebDisclosure

Basculer en Français

8691	Companies
150176	Keywords
85746	Articles
80546	Press releases

Home
Companies
SARTORIUS STED BIO

PRESS RELEASE

published on 03/25/2025 at 15:35, 2 months 3 days ago

Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. shareholders pass resolutions at Annual Shareholders' Meeting, elect new Board Members, and approve dividend payout. Company overview and financial calendar included

Board Members Financial Calendar Shareholders' Meeting Sartorius Stedim Biotech Dividend Payout
BRIEF

published on 03/05/2025 at 10:56, 2 months 23 days ago

Sartorius Stedim Biotech publie son capital social et ses droits de vote

Capital Social Droit De Vote Conformité Réglementaire Réglementation Française Sartorius Stedim
BRIEF

published on 03/05/2025 at 10:56, 2 months 23 days ago

Sartorius Stedim Biotech Reports Share Capital and Voting Rights

Share Capital Voting Rights Regulatory Compliance French Regulations Sartorius Stedim
PRESS RELEASE

published on 03/05/2025 at 10:51, 2 months 23 days ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Déclaration de Sartorius Stedim Biotech SA relative au nombre d'actions et de droits de vote. Communiqué réglementaire du 05-Mars-2025

Déclaration Capital Social AMF Sartorius Stedim Biotech Réglementaire
PRESS RELEASE

published on 03/05/2025 at 10:51, 2 months 23 days ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares the number of shares and voting rights making up the issued capital according to regulations

Voting Rights Shares Sartorius Stedim Biotech French Regulatory News Capital Declaration
BRIEF

published on 02/17/2025 at 11:01, 3 months 11 days ago

Mise à disposition du Document d'Enregistrement Universel 2024 par Sartorius Stedim Biotech

Résultats Financiers Sartorius Stedim Biotech Biopharmaceutique 2024 Document D'Enregistrement Universel
BRIEF

published on 02/17/2025 at 11:01, 3 months 11 days ago

Availability of the 2024 Universal Registration Document by Sartorius Stedim Biotech

Financial Results Sartorius Stedim Biotech 2024 Biopharmaceutical Universal Registration Document
PRESS RELEASE

published on 02/17/2025 at 10:57, 3 months 11 days ago

Sartorius Stedim Biotech SA: Communiqué de mise à disposition de documents
Sartorius Stedim Biotech met à disposition le Document d'Enregistrement Universel 2024, incluant les activités de 2024 et les objectifs 2025. Détails financiers disponibles en ligne

Sartorius Stedim Biotech États Financiers Objectifs 2025 Document D'Enregistrement Universel 2024 Activités 2024
PRESS RELEASE

published on 02/17/2025 at 10:57, 3 months 11 days ago

Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech's Universal Registration Document 2024 with business development and financial statements is now available. Learn about the leading biopharmaceutical company's global presence and innovative solutions

Financial Statements Sartorius Stedim Biotech Biopharmaceutical Industry Universal Registration Document Global Reach
PRESS RELEASE

published on 02/17/2025 at 10:56, 3 months 11 days ago

Sartorius Stedim Biotech SA: Communiqué de mise à disposition de documents
Communiqué de mise à disposition du Document d‘Enregistrement Universel 2024 de Sartorius Stedim Biotech SA incluant l'évolution des activités en 2024 et les objectifs pour 2025

Investor Relations Sartorius Stedim Biotech Biopharmaceutique Document D'Enregistrement Universel 2024 Worldwide Presence

Accesswire

Published on 05/28/2025 at 22:05, 1 hour 32 minutes ago

FP Newspapers Inc. Results of Annual Meeting of Shareholders
Published on 05/28/2025 at 22:00, 1 hour 37 minutes ago

Park Lawn Expands Presence in Colorado
Published on 05/28/2025 at 14:30, 9 hours 7 minutes ago

Volcon ePowersports Obtains Floor Plan Program with Dealer Direct Financing
Published on 05/28/2025 at 14:30, 9 hours 7 minutes ago

Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025
Published on 05/28/2025 at 14:30, 9 hours 7 minutes ago

MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program

View all ACCESSWIRE

EQS Group

Published on 05/28/2025 at 23:21, 16 minutes ago

EQS-Adhoc: Mynaric announces approval of the majority of the groups and confirmation of the StaRUG restructuring plan by the restructuring court
Published on 05/28/2025 at 23:06, 31 minutes ago

BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING AND CONCURRENT SHARE REPURCHASE
Published on 05/28/2025 at 21:40, 1 hour 57 minutes ago

EQS-Adhoc: Expected termination/redemption of the Trust Preferred Securities issued by IKB Funding Trust I on June 30, 2025
Published on 05/28/2025 at 20:16, 3 hours 21 minutes ago

DEAG: Growth in revenue and earnings in line with plan in Q1 2025 – strong start to financial year 2025
Published on 05/28/2025 at 19:07, 4 hours 30 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/28/2025 at 23:00, 37 minutes ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 37 minutes ago

Engagements collectifs de conservation de titres de la société
Published on 05/28/2025 at 18:39, 4 hours 58 minutes ago

Descriptif du programme de rachat d'actions - Mai 2025
Published on 05/28/2025 at 18:39, 4 hours 58 minutes ago

Description of share-buyback program - May 2025
Published on 05/28/2025 at 18:34, 5 hours 3 minutes ago

AXA a placé 1 milliard d’euros d’Obligations Restricted Tier 1 et 1 milliard d’euros d’Obligations Tier 2

View all LES ECHOS COMFI WIRE